EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum

Rabab Fatima

EXCLI Journal · 20.08.2026 · 25 · 1388-1391

DOI: 10.17179/excli2026-9655 ↗

Kurz gefasst

Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 20.08.2026. Verfasst von Rabab Fatima. Beteiligte Einrichtung: School of Health Sciences & Technology, UPES, Dehradun 248007, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • School of Health Sciences & Technology, UPES, Dehradun 248007, India.

Zitieren

APA

Fatima, R. (2026). Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum. EXCLI Journal, 25, 1388-1391. https://doi.org/10.17179/excli2026-9655

Vancouver

Fatima R. Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum. EXCLI Journal. 2026;25:1388-1391. doi:10.17179/excli2026-9655

BibTeX
@article{Fatima2026,
  author = {Fatima, Rabab},
  title = {Genetic and molecular advancements in combined hepatocellular-cholangiocarcinoma: Addressing a persistent clinical conundrum},
  journal = {EXCLI Journal},
  year = {2026},
  volume = {25},
  pages = {1388--1391},
  doi = {10.17179/excli2026-9655}
}
Kostenlos starten →